KREBS BIOCHEMICALS & INDUSTRIES
Back to Cashflow Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹13 Cr | ₹5.50 Cr | ₹37 Cr | ₹40 Cr | ₹38 Cr |
What is the latest Cash Flow from Financing Activities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹5.50 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹38 Cr |
How is Cash Flow from Financing Activities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 133.78 | |
| Mar2024 | ₹5.50 Cr | -85.26 | |
| Mar2023 | ₹37 Cr | -5.48 | |
| Mar2022 | ₹40 Cr | 4.90 | |
| Mar2021 | ₹38 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹123.5 Cr | -4.7% | 2.3% | -32.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -4.7% |
2.3% |
-32.6% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses